Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)

Sharon Elad, Judith E Raber-Durlacher, Michael T Brennan, Deborah P Saunders, Arno P Mank, Yehuda Zadik, Barry Quinn, Joel B Epstein, Nicole M A Blijlevens, Tuomas Waltimo, Jakob R Passweg, M Elvira P Correa, Göran Dahllöf, Karin U E Garming-Legert, Richard M Logan, Carin M J Potting, Michael Y Shapira, Yoshihiko Soga, Jacqui Stringer, Monique A Stokman, Samuel Vokurka, Elisabeth Wallhult, Noam Yarom, Siri Beier Jensen, Sharon Elad, Judith E Raber-Durlacher, Michael T Brennan, Deborah P Saunders, Arno P Mank, Yehuda Zadik, Barry Quinn, Joel B Epstein, Nicole M A Blijlevens, Tuomas Waltimo, Jakob R Passweg, M Elvira P Correa, Göran Dahllöf, Karin U E Garming-Legert, Richard M Logan, Carin M J Potting, Michael Y Shapira, Yoshihiko Soga, Jacqui Stringer, Monique A Stokman, Samuel Vokurka, Elisabeth Wallhult, Noam Yarom, Siri Beier Jensen

Abstract

Purpose: Hematology-oncology patients undergoing chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients are at risk for oral complications which may cause significant morbidity and a potential risk of mortality. This emphasizes the importance of basic oral care prior to, during and following chemotherapy/HSCT. While scientific evidence is available to support some of the clinical practices used to manage the oral complications, expert opinion is needed to shape the current optimal protocols.

Methods: This position paper was developed by members of the Oral Care Study Group, Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT) in attempt to provide guidance to the health care providers managing these patient populations.

Results: The protocol on basic oral care outlined in this position paper is presented based on the following principles: prevention of infections, pain control, maintaining oral function, the interplay with managing oral complications of cancer treatment and improving quality of life.

Conclusion: Using these fundamental elements, we developed a protocol to assist the health care provider and present a practical approach for basic oral care. Research is warranted to provide robust scientific evidence and to enhance this clinical protocol.

Figures

Fig. 1
Fig. 1
HSCT haematopoietic stem cells transplantation, CT chemotherapy, WHO world health organization, cGVHD chronic graft versus host disease, SCC squamous cell carcinoma
Fig. 2
Fig. 2
Suggested collaboration of hematology/oncology and oral medicine/dental teams as part of basic oral care for oncologic patients

References

    1. Bradley LL, Chambers M, Conklin CE, Fox PC, Garden AS, Haveman CW, Jackson SR, Lowenstein NL, Peterson DE, Schubert MM, Sonis ST. Oral health in cancer therapy. A guide for health care professionals. In: Rankin KV, Jones DL, Redding SW, editors. Oral health in cancer therapy. Texas: Dallas; 2003.
    1. Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012;62(6):400–422. doi: 10.3322/caac.21157.
    1. Epstein JB, Raber-Durlacher JE, Wilkins A, Chavarria MG, Myint H. Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(3):301–312. doi: 10.1016/j.tripleo.2008.12.006.
    1. Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®) , National Cancer Institute. Accessed on Aug. 2014
    1. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003;98(7):1531–1539. doi: 10.1002/cncr.11671.
    1. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000;8(1):33–39.
    1. Epstein J, Haveman C, Huber M, Peterson D, Plemons J, Sanfilippo N, Schubert M, Sonis S. Oral health in cancer therapy. A guide for the health care professionals. In: Rankin K, Jones D, Redding S, editors. Oral health in cancer therapy. Texas: San Antonio; 2008.
    1. Meier JK, Wolff D, Pavletic S, Greinix H, Gosau M, Bertz H, Lee SJ, Lawitschka A, Elad S. Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig. 2011;15(2):127–139. doi: 10.1007/s00784-010-0450-6.
    1. Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation (2008). Pediatr Dent 30 (7 Suppl):219–225
    1. Quinn B, Potting CM, Stone R, Blijlevens NM, Fliedner M, Margulies A, Sharp L. Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer. 2008;44(1):61–72. doi: 10.1016/j.ejca.2007.09.014.
    1. Bystricka E, Ghelase R, Gorican IK, Mazur E, Vokurka S. Oral cavity care in patients after high-dose chemotherapy and stem cell transplantation: the East Forum EBMT Nurses Group standard of care. Bone Marrow Transplant. 2012;47(1):149–150. doi: 10.1038/bmt.2011.19.
    1. McGuire DB, Correa ME, Johnson J, Wienandts P. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer. 2006;14(6):541–547. doi: 10.1007/s00520-006-0051-8.
    1. Rankin KV, Epstein J, Huber MA, Peterson DE, Plemons JM, Redding SS, Sanfillippo NJ, Schubert MM, Sonis ST. Oral health in cancer therapy. Tex Dent J. 2009;126(5):389–397.
    1. UK Oral Mucositis in Cancer. . Accessed on Jul. 2014
    1. Epstein JB, Parker IR, Epstein MS, Gupta A, Kutis S, Witkowski DM. A survey of National Cancer Institute-designated comprehensive cancer centers’ oral health supportive care practices and resources in the USA. Support Care Cancer. 2007;15(4):357–362. doi: 10.1007/s00520-006-0160-4.
    1. Migliorati CA, Woo SB, Hewson I, Barasch A, Elting LS, Spijkervet FK, Brennan MT. A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer. 2010;18(8):1099–1106. doi: 10.1007/s00520-010-0882-1.
    1. Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS, Spijkervet FK, Brennan MT. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010;18(8):1081–1087. doi: 10.1007/s00520-010-0902-1.
    1. Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D’Amato-Palumbo S, Fischer DJ, Martof A, Nicolatou-Galitis O, Patton LL, Elting LS, Spijkervet FK, Brennan MT. A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer. 2010;18(8):985–992. doi: 10.1007/s00520-010-0892-z.
    1. Elad S, Zadik Y, Hewson I, Hovan A, Correa ME, Logan R, Elting LS, Spijkervet FK, Brennan MT. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer. 2010;18(8):993–1006. doi: 10.1007/s00520-010-0900-3.
    1. Hong CH, Napenas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS, Spijkervet FK, Brennan MT. A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer. 2010;18(8):1007–1021. doi: 10.1007/s00520-010-0873-2.
    1. Peterson DE, Doerr W, Hovan A, Pinto A, Saunders D, Elting LS, Spijkervet FK, Brennan MT. Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies. Support Care Cancer. 2010;18(8):1089–1098. doi: 10.1007/s00520-010-0898-6.
    1. Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer. 2010;18(8):1033–1038. doi: 10.1007/s00520-010-0847-4.
    1. Epstein JB, Hong C, Logan RM, Barasch A, Gordon SM, Oberle-Edwards L, McGuire D, Napenas JJ, Elting LS, Spijkervet FK, Brennan MT. A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer. 2010;18(8):1023–1031. doi: 10.1007/s00520-010-0897-7.
    1. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napenas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bultzingslowen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer. 2010;18(8):1061–1079. doi: 10.1007/s00520-010-0837-6.
    1. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napenas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bultzingslowen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18(8):1039–1060. doi: 10.1007/s00520-010-0827-8.
    1. Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias VE, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV. Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(1):357–364. doi: 10.1007/s00520-012-1613-6.
    1. Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(1):333–341. doi: 10.1007/s00520-012-1605-6.
    1. Peterson DE, Ohrn K, Bowen J, Fliedner M, Lees J, Loprinzi C, Mori T, Osaguona A, Weikel DS, Elad S, Lalla RV. Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer. 2013;21(1):327–332. doi: 10.1007/s00520-012-1562-0.
    1. Raber-Durlacher JE, von Bultzingslowen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG, Pettersson BG, Soga Y, Spijkervet FK, Tissing WJ, Epstein JB, Elad S, Lalla RV. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(1):343–355. doi: 10.1007/s00520-012-1594-5.
    1. Jensen SB, Jarvis V, Zadik Y, Barasch A, Ariyawardana A, Hovan A, Yarom N, Lalla RV, Bowen J, Elad S. Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3223–3232. doi: 10.1007/s00520-013-1884-6.
    1. Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3191–3207. doi: 10.1007/s00520-013-1871-y.
    1. Yarom N, Ariyawardana A, Hovan A, Barasch A, Jarvis V, Jensen SB, Zadik Y, Elad S, Bowen J, Lalla RV. Systematic review of natural agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3209–3221. doi: 10.1007/s00520-013-1869-5.
    1. McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, Elad S, Gibson F, Oberle-Edwards LK, Bowen J, Lalla RV. Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3165–3177. doi: 10.1007/s00520-013-1942-0.
    1. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–1461.
    1. Elad S, Thierer T, Bitan M, Shapira MY, Meyerowitz C. A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantation. Oral Oncol. 2008;44(1):37–42. doi: 10.1016/j.oraloncology.2006.12.006.
    1. Elad S, Garfunkel AA, Or R, Michaeli E, Shapira MY, Galili D. Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients. Support Care Cancer. 2003;11(10):674–677. doi: 10.1007/s00520-003-0499-8.
    1. Durey K, Patterson H, Gordon K. Dental assessment prior to stem cell transplant: treatment need and barriers to care. Br Dent J. 2009;206(9):E19. doi: 10.1038/sj.bdj.2009.304.
    1. Zadik Y, Yarom N, Elad S (2012) Orofacial Neuropathy and Pain in Cancer Patients. In: Raffa R, Langford R, JV. PJ, Porreca F, Tallarida R (eds) Chemotherapy Induced Neuropathic Pain CRC press, pp 95–108
    1. Elad S, Raber-Durlacher J, Shapira MY. Oral complications of hematopoietic stem cell transplantation. In: Epstein J, editor. Davies A. New York: Oral complications of cancer and its management Oxford University Press; 2010. pp. 129–140.
    1. Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, Kanehira T, Yamamoto S, Kondo T, Endo T, Tanaka J, Hashino S, Nishio M, Imamura M, Kitagawa Y, Inoue N. Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer. 2012;20(2):367–373. doi: 10.1007/s00520-011-1116-x.
    1. Yamagata K, Arai C, Sasaki H, Takeuchi Y, Onizawa K, Yanagawa T, Ishibashi N, Karube R, Shinozuka K, Hasegawa Y, Chiba S, Bukawa H. The effect of oral management on the severity of oral mucositis during hematopoietic SCT. Bone Marrow Transplant. 2012;47(5):725–730. doi: 10.1038/bmt.2011.171.
    1. Peterson DE, Overholser CD. Increased morbidity associated with oral infection in patients with acute nonlymphocytic leukemia. Oral Surg Oral Med Oral Pathol. 1981;51(4):390–393. doi: 10.1016/0030-4220(81)90148-1.
    1. Greenberg MS, Cohen SG, McKitrick JC, Cassileth PA. The oral flor as a source of septicemia in patients with acute leukemia. Oral Surg Oral Med Oral Pathol. 1982;53(1):32–36. doi: 10.1016/0030-4220(82)90483-2.
    1. Raber-Durlacher JE, Laheij AM, Epstein JB, Epstein M, Geerligs GM, Wolffe GN, Blijlevens NM, Donnelly JP. Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study. Support Care Cancer. 2013;21(6):1621–1627. doi: 10.1007/s00520-012-1706-2.
    1. Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer. 1998;82(11):2275–2281. doi: 10.1002/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>;2-Q.
    1. Qutob AF, Allen G, Gue S, Revesz T, Logan RM, Keefe D. Implementation of a hospital oral care protocol and recording of oral mucositis in children receiving cancer treatment: a retrospective and a prospective study. Support Care Cancer. 2013;21(4):1113–1120. doi: 10.1007/s00520-012-1633-2.
    1. Newbrun E. Topical fluorides in caries prevention and management: a North American perspective. J Dent Educ. 2001;65(10):1078–1083.
    1. Ransier A, Epstein JB, Lunn R, Spinelli J. A combined analysis of a toothbrush, foam brush, and a chlorhexidine-soaked foam brush in maintaining oral hygiene. Cancer Nurs. 1995;18(5):393–396. doi: 10.1097/00002820-199510000-00009.
    1. Sambunjak D, Nickerson JW, Poklepovic T, Johnson TM, Imai P, Tugwell P, Worthington HV. Flossing for the management of periodontal diseases and dental caries in adults. Cochrane Database Syst Rev. 2011;12
    1. . . Accessed on Dec. 2012
    1. Hoffmann T, Bruhn G, Richter S, Netuschil L, Brecx M. Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clin Oral Investig. 2001;5(2):89–95. doi: 10.1007/s007840100114.
    1. Axelsson P, Lindhe J. Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. J Clin Periodontol. 1987;14(4):205–212. doi: 10.1111/j.1600-051X.1987.tb00968.x.
    1. Van Strydonck DA, Timmerman MF, van der Velden U, van der Weijden GA. Plaque inhibition of two commercially available chlorhexidine mouthrinses. J Clin Periodontol. 2005;32(3):305–309. doi: 10.1111/j.1600-051X.2005.00681.x.
    1. Van Strydonck DA, Slot DE, Van der Velden U, Van der Weijden F. Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. J Clin Periodontol. 2012;39(11):1042–1055. doi: 10.1111/j.1600-051X.2012.01883.x.
    1. Addy M. Oral hygiene products: potential for harm to oral and systemic health? Periodontol. 2008;2000(48):54–65. doi: 10.1111/j.1600-0757.2008.00253.x.
    1. de Souza RF, de Freitas Oliveira Paranhos H, Lovato da Silva CH, Abu-Naba’a L, Fedorowicz Z, Gurgan CA. Interventions for cleaning dentures in adults. Cochrane Database Syst Rev. 2009;4
    1. Elad S, Wexler A, Garfunkel AA, Shapira MY, Bitan M, Or R. Oral candidiasis prevention in transplantation patients: a comparative study. Clin Transplant. 2006;20(3):318–324. doi: 10.1111/j.1399-0012.2005.00484.x.
    1. Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol. 2010;46(6):452–456. doi: 10.1016/j.oraloncology.2010.03.012.
    1. Sonis ST. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007;5(9 Suppl 4):3–11.
    1. Sonis ST. Oral mucositis. Anticancer Drugs. 2011;22(7):607–612. doi: 10.1097/CAD.0b013e3283462086.
    1. Benoliel R, Epstein J, Eliav E, Jurevic R, Elad S. Orofacial pain in cancer: part I–mechanisms. J Dent Res. 2007;86(6):491–505. doi: 10.1177/154405910708600604.
    1. Epstein JB, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer: part II–clinical perspectives and management. J Dent Res. 2007;86(6):506–518. doi: 10.1177/154405910708600605.
    1. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC. Scoring oral mucositis. Oral Oncol. 1998;34(1):63–71. doi: 10.1016/S1368-8375(97)00065-1.
    1. Barasch A, Elad S, Altman A, Damato K, Epstein J. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer. 2006;14(6):528–532. doi: 10.1007/s00520-006-0066-1.
    1. Boer CC, Correa ME, Miranda EC, de Souza CA. Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant. 2010;45(4):705–711. doi: 10.1038/bmt.2009.237.
    1. Epstein JB, Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol. 2010;46(2):77–81. doi: 10.1016/j.oraloncology.2009.11.008.
    1. Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant. 2001;27(Suppl 2):S3–S11. doi: 10.1038/sj.bmt.1702863.
    1. Mohty M, Apperley JF. Long-term physiological side effects after allogeneic bone marrow transplantation. Hematology Am Soc Hematol Educ Program. 2010;2010:229–236. doi: 10.1182/asheducation-2010.1.229.
    1. Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am. 2008;52(1):79–109. doi: 10.1016/j.cden.2007.10.004.
    1. Strietzel FP, Lafaurie GI, Mendoza GR, Alajbeg I, Pejda S, Vuletic L, Mantilla R, Falcao DP, Leal SC, Bezerra AC, Tran SD, Menard HA, Kimoto S, Pan S, Martin-Granizo RA, Lozano ML, Zunt SL, Krushinski CA, Melilli D, Campisi G, Paderni C, Dolce S, Yepes JF, Lindh L, Koray M, Mumcu G, Elad S, Zeevi I, Barrios BC, Lopez Sanchez RM, Beiski BZ, Wolff A, Konttinen YT. Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis Rheum. 2011;63(1):180–190. doi: 10.1002/art.27766.
    1. Castellarin P, Stevenson K, Biasotto M, Yuan A, Woo SB, Treister NS. Extensive dental caries in patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2012;18(10):1573–1579. doi: 10.1016/j.bbmt.2012.04.009.
    1. Ship JA, McCutcheon JA, Spivakovsky S, Kerr AR. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth. J Oral Rehabil. 2007;34(10):724–732. doi: 10.1111/j.1365-2842.2006.01718.x.
    1. Shen P, Manton DJ, Cochrane NJ, Walker GD, Yuan Y, Reynolds C, Reynolds EC. Effect of added calcium phosphate on enamel remineralization by fluoride in a randomized controlled in situ trial. J Dent. 2011;39(7):518–525. doi: 10.1016/j.jdent.2011.05.002.
    1. Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kalhs P, Krutmann J, Honigsmann H, Ciovica M, Knobler RM. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998;92(9):3098–3104.
    1. Treister N, Duncan C, Cutler C, Lehmann L. How we treat oral chronic graft-versus-host disease. Blood. 2012;120(17):3407–3418. doi: 10.1182/blood-2012-05-393389.
    1. Mawardi H, Elad S, Correa ME, Stevenson K, Woo SB, Almazrooa S, Haddad R, Antin JH, Soiffer R, Treister N. Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant. 2011;46(6):884–891. doi: 10.1038/bmt.2011.77.
    1. Sivolella S, Lumachi F, Stellini E, Favero L. Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease. Anticancer Res. 2013;33(5):1793–1797.
    1. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update. J Oral Maxillofac Surg. 2014
    1. Chaushu G, Bercovici M, Dori S, Waller A, Taicher S, Kronenberg J, Talmi YP (2000) Salivary flow and its relation with oral symptoms in terminally ill patients. Cancer 88 (5):984–987. doi:10.1002/(SICI)1097-0142(20000301)88:5%3C984::AID-CNCR6%;2%E2%80%930 [pii]
    1. Chaushu G, Itzkovitz-Chaushu S, Yefenof E, Slavin S, Or R, Garfunkel AA. A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79(2):164–169. doi: 10.1016/S1079-2104(05)80276-8.
    1. Laaksonen M, Ramseier AM, Rovo A, Jensen SB, Raber-Durlacher JE, Zitzmann NU, Waltimo T. Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation. J Dent Res. 2011;90(10):1177–1182. doi: 10.1177/0022034511414156.
    1. Glenny AM, Gibson F, Auld E, Coulson S, Clarkson JE, Craig JV, Eden OB, Khalid T, Worthington HV, Pizer B. The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer. Eur J Cancer. 2010;46(8):1399–1412. doi: 10.1016/j.ejca.2010.01.023.
    1. Council on Clinical Affairs (2013) Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. Pediatr Dent 35(5):E185–193
    1. US Food and Drug Administration (2014) FDA Drug Safety Communication: FDA recommends not using lidocaine to treat teething pain and requires new Boxed Warning. Accessed Jul. 2014
    1. Bagesund M, Richter S, Agren B, Ringden O, Dahllof G. Scintigraphic study of the major salivary glands in pediatric bone marrow transplant recipients. Bone Marrow Transplant. 2000;26(7):775–779. doi: 10.1038/sj.bmt.1702556.
    1. American Academy of Pediatric Dentistry Clinical Affairs Committee, American Academy of Pediatric Dentistry Council on Clinical Affairs, (2005) Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. Pediatr Dent 27(7 Suppl):170–175

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner